Mutagen properties of water-soluble polysaccharides from Acorus calamus

A. M. Gur'ev, M. V. Belousov, R. R. Akhmedzhanov, M. S. Yusubov, O. L. Voronova, G. V. Karpova, A. A. Churin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Mutagenic properties of water soluble polysaccharides (WSPS) extracted from Acorus calamus L. have been studied. Neither a single intravenous injection nor a course intraperitoneal introduction of WSPS in a dose of 1/2 LD50 to mice of the CBA/CaLac line increases the level of cytogenetic disorders in the bone marrow cells. The investigation of WSPS by means of the somatic mosaicism test showed that the given dose of WSPS does not increase the rate of mutant spots on Drosophila wings.

Original languageEnglish
Pages (from-to)43-45
Number of pages3
JournalEksperimental'naya i Klinicheskaya Farmakologiya
Volume73
Issue number8
Publication statusPublished - 2010

Fingerprint

Acorus
Mutagens
Polysaccharides
Water
Inbred CBA Mouse
Mosaicism
Lethal Dose 50
Cytogenetics
Intravenous Injections
Bone Marrow Cells
Drosophila
Bone
Cells

Keywords

  • Acorus calamus
  • Genotoxicity
  • Mutagenicity
  • Water soluble polysaccharides

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Mutagen properties of water-soluble polysaccharides from Acorus calamus. / Gur'ev, A. M.; Belousov, M. V.; Akhmedzhanov, R. R.; Yusubov, M. S.; Voronova, O. L.; Karpova, G. V.; Churin, A. A.

In: Eksperimental'naya i Klinicheskaya Farmakologiya, Vol. 73, No. 8, 2010, p. 43-45.

Research output: Contribution to journalArticle

@article{e98b683bc8514e888c049dc627be8eaf,
title = "Mutagen properties of water-soluble polysaccharides from Acorus calamus",
abstract = "Mutagenic properties of water soluble polysaccharides (WSPS) extracted from Acorus calamus L. have been studied. Neither a single intravenous injection nor a course intraperitoneal introduction of WSPS in a dose of 1/2 LD50 to mice of the CBA/CaLac line increases the level of cytogenetic disorders in the bone marrow cells. The investigation of WSPS by means of the somatic mosaicism test showed that the given dose of WSPS does not increase the rate of mutant spots on Drosophila wings.",
keywords = "Acorus calamus, Genotoxicity, Mutagenicity, Water soluble polysaccharides",
author = "Gur'ev, {A. M.} and Belousov, {M. V.} and Akhmedzhanov, {R. R.} and Yusubov, {M. S.} and Voronova, {O. L.} and Karpova, {G. V.} and Churin, {A. A.}",
year = "2010",
language = "English",
volume = "73",
pages = "43--45",
journal = "Eksperimental'naya i Klinicheskaya Farmakologiya",
issn = "0869-2092",
publisher = "Izdatelstvo Meditsina",
number = "8",

}

TY - JOUR

T1 - Mutagen properties of water-soluble polysaccharides from Acorus calamus

AU - Gur'ev, A. M.

AU - Belousov, M. V.

AU - Akhmedzhanov, R. R.

AU - Yusubov, M. S.

AU - Voronova, O. L.

AU - Karpova, G. V.

AU - Churin, A. A.

PY - 2010

Y1 - 2010

N2 - Mutagenic properties of water soluble polysaccharides (WSPS) extracted from Acorus calamus L. have been studied. Neither a single intravenous injection nor a course intraperitoneal introduction of WSPS in a dose of 1/2 LD50 to mice of the CBA/CaLac line increases the level of cytogenetic disorders in the bone marrow cells. The investigation of WSPS by means of the somatic mosaicism test showed that the given dose of WSPS does not increase the rate of mutant spots on Drosophila wings.

AB - Mutagenic properties of water soluble polysaccharides (WSPS) extracted from Acorus calamus L. have been studied. Neither a single intravenous injection nor a course intraperitoneal introduction of WSPS in a dose of 1/2 LD50 to mice of the CBA/CaLac line increases the level of cytogenetic disorders in the bone marrow cells. The investigation of WSPS by means of the somatic mosaicism test showed that the given dose of WSPS does not increase the rate of mutant spots on Drosophila wings.

KW - Acorus calamus

KW - Genotoxicity

KW - Mutagenicity

KW - Water soluble polysaccharides

UR - http://www.scopus.com/inward/record.url?scp=77957357016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957357016&partnerID=8YFLogxK

M3 - Article

C2 - 20919559

AN - SCOPUS:77957357016

VL - 73

SP - 43

EP - 45

JO - Eksperimental'naya i Klinicheskaya Farmakologiya

JF - Eksperimental'naya i Klinicheskaya Farmakologiya

SN - 0869-2092

IS - 8

ER -